Entrada Therapeutics, Inc. share price logo

Entrada Therapeutics, Inc. Share Price

NASDAQ: TRDA

Small Cap

$11.87

-0.72

(-5.72%)

as on

Entrada Therapeutics, Inc. Stock Performance

as on March 19, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $11.70
    $12.48
    downward going graph

    1.43%

    Downside

    5.14%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $4.93
    $13.66
    downward going graph

    58.47%

    Downside

    15.04%

    Upside

    downward going graph

Entrada Therapeutics, Inc. share price movements today

Previous Close
$12.59
Open
$12.48
Volume
1.2M
Day's Low - High
$11.70 - $12.48
52 Week Low - High
$4.93 - $13.66

Entrada Therapeutics, Inc. Historical Returns

1 Month Return
+ 4.12 %
3 Month Return
+ 8.2 %
1 Year Return
+ 10.51 %
3 Year Return
-23.5 %
5 Year Return
0 %

Entrada Therapeutics, Inc. Stock Fundamentals & Key Indicators

Check Entrada Therapeutics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$482.0M

EPS (TTM)

-3.7917

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

6.23

Industry PE ratio

-4.366825938566553

PEG Ratio

0

EBITDA

-151.9M

Revenue (TTM)

25.4M

Profit Margin

0.00%

Return On Equity TTM

-39.13%

Entrada Therapeutics, Inc. Stock Valuation

Track how Entrada Therapeutics, Inc. P/E has moved over time to understand its valuation trends.

Entrada Therapeutics, Inc. in the last 5 years

  • Overview

  • Trends

Lowest (-56.99x)

December 31, 2023

Industry (-4.37x)

March 19, 2026

Today (6.23x)

March 19, 2026

Highest (22.44x)

March 31, 2024

LowHigh

Today’s Price to Earnings Ratio: 6.23x

Entrada Therapeutics, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Entrada Therapeutics, Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Entrada Therapeutics, Inc. image
Entrada Therapeutics, Inc.
BUY$482.0MNA6.230.00%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$42.5B118.37%136.938.45%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$117.5B108.96%30.2132.94%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$33.2BNA116.335.37%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$80.2B57.09%18.3231.41%

Stock Returns calculator for Entrada Therapeutics, Inc. Stock including INR - Dollar returns

The Entrada Therapeutics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Entrada Therapeutics, Inc. investment value today

Current value as on today

₹1,17,485

Returns

₹17,485

(+17.49%)

Returns from Entrada Therapeutics, Inc. Stock

₹10,419 (+10.42%)

Dollar Returns*

₹7,067 (+7.07%)

Analyst Recommendation on Entrada Therapeutics, Inc. Stock

Based on 10 analysts

BUY

90.00%

Buy

10.00%

Hold

0.00%

Sell

Based on 10 analysts, 90% of analysts recommend a 'BUY' rating for Entrada Therapeutics, Inc.. Average target price of $20

Entrada Therapeutics, Inc. Share Price Target

Get share price movements and forecasts by analysts on Entrada Therapeutics, Inc..

What analysts predicted

40.65%UPSIDE

Target Price

$20

Current Price

$11.87

Analyzed by

10 Analysts

Target

$20.00

Entrada Therapeutics, Inc. target price $20, a slight upside of 40.65% compared to current price of $11.87. According to 10 analysts rating.

Entrada Therapeutics, Inc. Stock’s Investor Sentiment and Interest

Search interest for Entrada Therapeutics, Inc. Stock has decreased by -34% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-34% versus previous 30 day period

Entrada Therapeutics, Inc. Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
43
41
59
94
19
37
20
1
1
1
Gross Profit
21
41
59
94
19
37
20
1
-36
0
Operating Income
14
4
21
53
-21
-5
-21
-46
-47
-42
EBITDA
14
5
22
54
-20
-4
-20
-45
-42
-41
Interest Expense
-
4
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
1
1
0
Income Before Tax
52
9
25
57
-15
0
-17
-42
-43
-39
Income Tax Expense
17
18
1
2
-1
-1
-
0
0
0
Net Income
35
-9
23
55
-14
1
-17
-43
-44
-39
Net Profit Margin
81.08%
-22.81%
39.74%
58.11%
-71.70%
3.02%
-84.39%
-2210.41%
-2734.45%
-3014.93%

Entrada Therapeutics, Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
25
129
210
25
Gross Profit
0
0
-1
-1
129
210
21
Operating Income
-11
-26
-51
-97
-3
47
-155
EBITDA
-11
-26
-50
-95
0
50
-142
Interest Expense
-
-
0
2
-
-
-
Depreciation
0
0
1
1
2
3
4
Income Before Tax
-5
-26
-51
-94
12
66
-142
Income Tax Expense
0
0
-1
-7
18
0
0
Net Income
-4
-26
-50
-87
-6
65
-143
Net Profit Margin
0.00%
0.00%
0.00%
-346.23%
-5.18%
31.13%
-565.48%

Entrada Therapeutics, Inc. Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-9
23
55
-14
1
-17
-43
-44
-39
Operating Cash Flow
-4
-25
39
-24
-31
-38
-29
-28
-32
Investing Cash Flow
19
26
-24
-82
53
4
33
49
29
Financing Cash Flow
0
0
101
0
1
0
0
0
0
Change in Cash
15
0
116
-107
23
-33
4
20
-2

Entrada Therapeutics, Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-26
-51
-94
-6
65
-143
Operating Cash Flow
-25
-50
-93
139
-41
-128
Investing Cash Flow
-2
-4
-148
-138
-27
116
Financing Cash Flow
50
307
0
21
102
0
Change in Cash
22
252
-245
22
33
-10

Global Institutional Holdings in Entrada Therapeutics, Inc.

Funds
Holdings
BlackRock Inc
5.34%
Wellington Management Company LLP
2.73%
Renaissance Technologies Corp
1%
StepStone Group LLC
1.99%
Geode Capital Management, LLC
1.69%
See all

Insights on Entrada Therapeutics, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 6 months, TRDA stock has moved up by 119.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 24.2% return, outperforming this stock by 13.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 69.7% return, outperforming this stock by 93.2%

About Entrada Therapeutics, Inc.

entrada therapeutics is building the leading intracellular biologics company to transform the treatment of devastating diseases. entrada was co-founded in 2016 by 5am ventures, a leading life sciences venture capital firm.
OrganisationEntrada Therapeutics, Inc.
HeadquartersOne Design Center Place, Boston, MA, United States, 02210
IndustryServices
CEOMr. Dipal Doshi
E-voting on sharesClick here to vote

Key Management of Entrada Therapeutics, Inc.

Name

Title

Mr. Kory James Wentworth CPA

CFO & Treasurer

Dr. Jared Cohen J.D., Ph.D.

General Counsel

Ms. Karla MacDonald

Chief Corporate Affairs Officer

Mr. Kevin Healy Ph.D.

Senior Vice President of Regulatory Affairs

Sandeep Basnet

Head of Information Technology

Mr. Dipal Doshi

CEO & Director

Mr. Nathan J. Dowden

President & COO

Dr. Natarajan Sethuraman Ph.D.

President of Research & Development

FAQs

What is Entrada Therapeutics, Inc. share price today?

Entrada Therapeutics, Inc. share price today is $11.87 as on at the close of the market. Entrada Therapeutics, Inc. share today touched a day high of $12.48 and a low of $11.7.

What is the 52 week high and 52 week low for Entrada Therapeutics, Inc. share?

Entrada Therapeutics, Inc. share touched a 52 week high of $13.66 on and a 52 week low of $4.93 on . Entrada Therapeutics, Inc. stock price today i.e. is closed at $11.87,which is 13.07% down from its 52 week high and 140.77% up from its 52 week low.

What is Entrada Therapeutics, Inc.'s market capitalisation today?

Entrada Therapeutics, Inc. market capitalisation is $0.00T as on .

How to invest in Entrada Therapeutics, Inc. Stock (TRDA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Entrada Therapeutics, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Entrada Therapeutics, Inc. Shares that will get you 0.1264 shares as per Entrada Therapeutics, Inc. share price of $11.87 per share as on March 19, 2026 at 1:29 am IST.

What is the minimum amount required to buy Entrada Therapeutics, Inc. Stock (TRDA) from India?

Indian investors can start investing in Entrada Therapeutics, Inc. (TRDA) shares with as little as ₹92.634 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹926.34 in Entrada Therapeutics, Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Entrada Therapeutics, Inc. share’s latest price of $11.87 as on March 19, 2026 at 1:29 am IST, you will get 0.8425 shares of Entrada Therapeutics, Inc.. Learn more about fractional shares .